Medicare reimbursement trends from 2000 to 2020 in head and neck surgical oncology.
Medicare reimbursement
head and neck cancer
head and neck surgery
health economics
health policy
Journal
Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
revised:
28
02
2022
received:
12
10
2021
accepted:
05
04
2022
pubmed:
14
4
2022
medline:
9
6
2022
entrez:
13
4
2022
Statut:
ppublish
Résumé
Considering limited data exploring reimbursement trends at the subspecialty level within head and neck surgical oncology, we sought to characterize these trends for head and neck-specific codes from 2000 to 2020. Using the Centers for Medicare and Medicaid Services' Physician Fee Schedule Look-Up Tool, reimbursement data, adjusted to 2020 U.S. dollars, for 37 head and neck surgical oncologic procedure codes were collected from 2000 to 2020. From 2000 to 2020, despite gross reimbursement for all head and neck procedures increasing by 23.2%, when adjusted for inflation, physician reimbursement decreased by 19.4%. Only 4 of 37 examined codes increased in net reimbursement over the study period. Medicare reimbursement for the most common head and neck oncologic procedure codes decreased from 2000 to 2020. Further research is necessary to explore the implications of these trends on the delivery of patient care.
Sections du résumé
BACKGROUND
Considering limited data exploring reimbursement trends at the subspecialty level within head and neck surgical oncology, we sought to characterize these trends for head and neck-specific codes from 2000 to 2020.
METHODS
Using the Centers for Medicare and Medicaid Services' Physician Fee Schedule Look-Up Tool, reimbursement data, adjusted to 2020 U.S. dollars, for 37 head and neck surgical oncologic procedure codes were collected from 2000 to 2020.
RESULTS
From 2000 to 2020, despite gross reimbursement for all head and neck procedures increasing by 23.2%, when adjusted for inflation, physician reimbursement decreased by 19.4%. Only 4 of 37 examined codes increased in net reimbursement over the study period.
CONCLUSION
Medicare reimbursement for the most common head and neck oncologic procedure codes decreased from 2000 to 2020. Further research is necessary to explore the implications of these trends on the delivery of patient care.
Identifiants
pubmed: 35416360
doi: 10.1002/hed.27064
pmc: PMC9325383
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1616-1622Informations de copyright
© 2022 The Authors. Head & Neck published by Wiley Periodicals LLC.
Références
Head Neck. 2022 Jul;44(7):1616-1622
pubmed: 35416360
Laryngoscope. 2021 Mar;131(3):496-501
pubmed: 32619309
J Oncol Pract. 2018 Feb;14(2):e103-e112
pubmed: 29272202
Ann Surg. 2005 Jun;241(6):929-38; discussion 938-40
pubmed: 15912042
World Neurosurg. 2021 May;149:e714-e720
pubmed: 33540094
J Arthroplasty. 2020 Sep;35(9):2318-2322
pubmed: 32423758
Neurosurg Focus. 2014 Nov;37(5):E12
pubmed: 25363429
JAMA Surg. 2020 Jun 1;155(6):493-501
pubmed: 32293659
J Oral Maxillofac Surg. 2019 Apr;77(4):698-702
pubmed: 30576668
Laryngoscope. 2021 Jun;131(6):E1785-E1791
pubmed: 33331651
Otol Neurotol. 2021 Apr 1;42(4):505-509
pubmed: 33351566
JAMA. 2015 May 26;313(20):2025-6
pubmed: 25885640
Med Care. 2019 Sep;57(9):680-687
pubmed: 31295166